Building on an Approved Base

Tesamorelin is one of the few GHRH analogs with an FDA indication — for HIV-associated visceral fat. Pairing it with ipamorelin follows the classic GHRH+GHRP synergy logic, but starts from a clinically validated base.

Members note that while tesamorelin alone has clinical data, the specific combination does not — so it's discussed as a rational extension of validated components rather than a validated combination itself.